Purpose of Review Obesity in the USA has been on a constant rise since the Center for Disease Control and Prevention (CDC) began tracking it over 50 years ago. Despite focused attention on this epidemic, pharmacological treatments aimed at obesity are lacking. Here, we briefly give perspective on the central and peripheral mechanisms underlying feeding behaviors and describe the existing pharmacological treatments for obesity. With this lens, I suggest future targets for the treatment of obesity. Recent Findings Given the development of genetic and molecular tools, understanding of how energy expenditure is modulated is becoming more nuanced. There is growing evidence for a link between obesity and addiction, which should be utilized in the development of new pharmacological treatments. Summary More focus is needed on identifying targets for anti-obesity pharmacology. In doing so, research should include intensive investigation of the brain’sreward circuitry. . . . Keywords Obesity Pharmacology Addiction Dopamine Introduction burden, obesity has taken center stage as a national health concern. However, despite focused efforts, obesity rates In the USA, rates of obesity have nearly tripled since the remain unaffected in the USA . Center for Disease Control and Prevention (CDC) first Historically, obesity has been considered a
Current Addiction Reports – Springer Journals
Published: May 7, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud